Scientific foundation, patents, and new product introductions of biotechnology and pharmaceutical firms

R and D Management

Volumn 43, Issue 5, 2013, Pages 433-446

  Watts, Allison D ^a   Hamilton, Robert D ^b  

^a SHIPPENSBURG UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886293512     PISSN: 00336807     EISSN: 14679310     Source Type: Journal    
DOI: 10.1111/radm.12023     Document Type: Article

References (79)

1. Akella, J., Manyika, J.M., and Roberts, R.P. (2003) What high tech can learn from slow-growth industries. McKinsey Quarterly, 4, 71-81.
2. Ali, A., Kalwani, M.U., and Kovenock, D. (1993) Selecting product development projects: pioneering versus incremental innovation strategies. Management Science, 39, 3, 255-274.
3. Arrow, K.J. (1969) Classificatory notes on the production and transmission of technological knowledge. American Economic Association, 59, 29-35.
4. Atuahene-Gima, K. and Evangelista, F. (2000) Cross-functional influence in new product development: an exploratory study of marketing and R&D perspectives. Management Science, 46, 10, 1269-1284.
5. Bartholowmew, S. (1997) National systems of biotechnology innovation: complex interaction in the global system. Journal of International Business Studies, 28, 2, 241-266.
6. Bierly, P. and Chakrabarti, A. (1996) Generic knowledge strategies in the U.S. pharmaceutical industry. Strategic Management Journal, 17, Winter Special, 123-135.
7. Bottazzi, G., Dosi, G., Lippi, M., Pammolli, F., and Riccaboni, M. (2001) Innovation and corporate growth in the evolution of the drug industry. International Journal of Industrial Organizations, 19, 1161-1187.
8. Bower, J.L. and Christensen, C.M. (1995) Disruptive technologies: catching the wave. Harvard Business Review, January-February, 43-53.
9. Callaway, S.K. and Hamilton, R.D. (2006) Exploring disruptive technology: the structure and control of internal corporate ventures. International Journal of Organizational Analysis, 14, 2, 87-106.
10. Canner, N. and Mass, N.J. (2005) Turn R&D upside down. Research Technology Management, March-April, 17-21.
11. Castellacci, F., Grodal, S., Mendonca, S., and Wibe, M. (2005) Advances and challenges in innovation studies. Journal of Economic Issues, XXXIX, 1, 91-121.
12. Caufield, T. (2004) Biotechnology and the popular press: hype and the selling of science. Trends in Biotechnology, 22, 7, 337-339.
13. Chalmers, A.F. (1999) What Is This Thing Called Science? 3rd edn. Queensland, Australia: University of Queensland Press.
14. Charue-Duboc, F. (2006) A theoretical framework for understanding the organisation of the R&D function: an empirical illustration from the chemical and pharmaceutical industry. International Journal of Innovation Management, 10, 4, 455-476.
15. Chase, M. (2007) How genentech wins at blockbuster drugs: CEO to critics of prices: 'give me a break'. Retrieved June 5, 2007 from http://online.wsj.com/article/SB118100806142024548.html?mod=hps_us_editors_picks
16. Christensen, C.M., Craig, T., and Hart, S. (2001) The great disruption. Foreign Affairs, 80, 2, 80-95.
17. Christensen, C.M., Johnson, M.W., and Rigby, D.K. (2002) Foundations for growth. MIT Sloan Management Review, 43, 3, 22-31.
18. Christensen, C.M. and Overdorf, M. (2000) Meeting the challenge of disruptive change. Harvard Business Review, 78, 2, 66-75.
19. Christensen, C.M., Raynor, M., and Verlinden, M. (2001) Skate to where the money will be. Harvard Business Review, 79, 10, 72-80.
20. Cohen, W.M. and Levinthal, D.A. (1989) Innovation and learning: the two faces of R&D. The Economic Journal, September, 369-396.
21. Cohen, W.M. and Levinthal, D.A. (1990) Absorptive capacity: a new perspective on learning and innovation. Administrative Science Quarterly, 35, 128-152.
22. Cohen, W.M. and Levinthal, D.A. (1994) Fortune favors the prepared firm. Management Science, 40, 2, 227-251.
23. Cohen, W.M., Nelson, R.R., and Walsh, J.P. (2002) Links and impacts: the influence of public research on industrial R&D. Management Science, 48, 1, 1-23.
24. Coombs, J.E. and Bierly, P.E. (2001) Looking through the kaleidoscope: measuring technological capability and performance. Paper presented at the Academy of Management.
25. Deeds, D.L., DeCarolis, D., and Coombs, J.E. (1998) Firm-specific resources and wealth creation in high-technology ventures: evidence from newly public biotechnology firms. Entrepreneurship Theory and Practice, Spring, 55-73.
26. Dewar, R. and Dutton, J.E. (1986) The adoption of radical and incremental innovations: an empirical analysis. Management Science, 32, 11, 1422-1433.
27. Don't laugh at gilded butterflies. (2004) The Economist, 371, 71-73.
28. Dosi, G. (1982) Technological paradigms and technological trajectories. Research Policy, 11, 147-162.
29. Dunlap-Hinkler, D. (2005) The determinants of corporate innovativeness: a cross-national knowledge perspective. Unpublished dissertation, Temple, Philadelphia.
30. Dunlap-Hinkler, D. and Kotabe, M. (2010) A story of breakthrough versus incremental innovation: corporate entreprenuership in the global pharmaceutical industry. Strategic Entrepreneurship Journal, 4, 2, 106-127.
31. Feldman, M.P. and Audretsch, D.B. (1999) Innovation in cities: science-based diversity, specialization, and localized competition. European Economic Review, 43, 2, 409-429. Retrieved April 5, 2004, from http://www.sciencedirect.com/science/article/pii/S0014292198000476
32. Fleming, L. and Sorenson, O. (2003) Navigating the technology landscape of innovation. MIT Sloan Management Review, Winter, 15-23.
33. Gatignon, H., Tushman, M.L., Smith, W., and Anderson, P. (2002) A structural approach to assessing innovation: construct development of innovation locus, type, and characteristics. Management Science, 48, 9, 1103-1122.
34. Gomory, R.E. (1989) From the 'Ladder of Science' to the product development cycle. Harvard Business Review, November-December, 99-105.
35. Hardstone, G.A.P. (2004) Capabilities, structures and strategies re-examined: incumbent firms and the emergence of complex product systems (CoPS) in mature industries. Technology Analysis & Strategic Management, 16, 2, 173-196.
36. Hill, C.W.L. and Rothaermel, F.T. (2003) The performance of incumbent firms in the face of radical technological innovation. Academy of Management Review, 28, 2, 257-274.
37. Jaffe, A.B. (1998) Patents, patent citations, and the dynamics of technological change. NBER Reporter, Summer, 8-11.
38. Jones, N. (2003) Competing after radical technological change: the significance of product line management strategy. Strategic Management Journal, 24, 13, 1265-1287.
39. Knellar, R. (2010) The importance of new companies for drug discovery: origins of a decade of new drugs. Nature Reviews|Drug Discovery, 9, November, 867-882.
40. Koopmann, G. and Münnich, F. (1999) National and international development in technology - trends, patterns and implication for policy. HWWA Discussion Paper, 76, 1-29.
41. Kortum, S. and Lerner, J. (1999) What is behind the recent surge in patenting? Research Policy, 28, 1-22.
42. Kuhn, T.S. (1996) The Structure of Scientific Revolutions, 3rd edn. Chicago, IL: The University Press of Chicago.
43. Lacetera, N. and Orsenigo, L. (2001) Political regimes, technological regimes and innovation in the evolution of the pharmaceutical industry in the USA and in Europe. Paper presented at the Conference on Evolutionary Economics, Johns Hopkins University, Baltimore.
44. Lane, P.J. and Lubatkin, M.H. (1998) Relative absorptive capacity and interorganizational learning. Strategic Management Journal, 19, 461-477.
45. Lee, C.-Y. (2002) A simple model of R&D: an extension of the Dorfman-Steiner theorem. Applied Economics Letters, 9, 449-452.
46. Leonard-Barton, D. (1995) Wellsprings of Knowledge: Building and Sustaining the Sources of Innovation. Boston, MA: Harvard Business School Press.
47. Madhavan, R. and Grover, R. (1998) From embedded knowledge to embodied knowledge: new product development as knowledge management. Journal of Marketing, 62, October, 1-12.
48. McAdam, R., McAdam, M., and Brown, V. (2009) Proof of concept processes in UK university technology transfer: an absorptive capacity perspective. R&D Management, 39, 2, 192-210.
49. McMillan, G.S., Klavans, R.A., and Hamilton, R.D. (1995) Firm management of scientific information: some predictors and implications of openness versus secrecy. R&D Management, 25, 4, 411-419.
50. McMillan, G.S., Mauri, A., and Hamilton, R.D. (2003) The impact of publishing and patenting activities on new product development and firm performance: the case of the US pharmaceutical industry. International Journal of Innovation Management, 7, 2, 213-223.
51. McMillan, G.S., Narin, F., and Deeds, D.L. (2000) An analysis of the critical role of public science in innovation: the case of biotechnology. Research Policy, 29, 1-8.
52. Mote, J., Boylan, R., and Rice, M. (2001) A modeling view of breakthrough innovation. Engineering Management Journal, 13, 3, 35-40.
53. Mudambi, R. and Mudambi, S.M. (2005) Multinational enterprise knowledge flows: the effect of government inward investment policy. Management International Review, 45, 2, 155-178.
54. Mulligan, R.C. (1993) The basic science of gene therapy. Science, 260, 926-932.
55. Mullin, R. (2004) Priming the pipeline. Chemical and Engineering News, 82, 23-36.
56. Mullin, R. (2005) The next wave in biopharmaceuticals. Chemical and Engineering News, 83, 14-19.
57. NSF. (2013) Definitions of research and development: an annotated compilation of official sources. Research and Development: National Trends and International Comparisons. pp. 4-55. Retrieved May 1, 2013, from http://www.nsf.gov/statistics/seind12/pdf/c04.pdf
58. O'Connor, G.C. and Ayers, A.D. (2005) Building a radical innovation competency. Research Technology Management, January-February, 23-31.
59. O'Connor, G.C. and Rice, M.P. (2001) Opportunity recognition and breakthrough innovation in large established firms. California Management Review, 43, 2, 95-116.
60. Oliver, A.L. and Liebeskind, J.P. (1998) Three levels of networking for sourcing intellectual capital in biotechnology. International Studies of Management and Organization, 27, 4, 76-103.
61. Parascandola, J. (2000) The pharmaceutical sciences in America, 1852-1902. Journal of the American Pharmaceutical Association, 40, 733-735. Retrieved May 20, 2005, from http://www.lhncbc.nlm.nih.gov/publication/lhncbc-2000-045
62. Paugh, J. and Lafrance, J.C. (1997) The U.S. biotechnology industry. Retrieved June 19 2006, from http://www.bio-nica.info/biblioteca/Paugh1997BiotechnologyIndustry.pdf
63. Pisano, G.P. (2006) The science-based business. In: Pisano, G.P. (ed.), Science Business: The Promise, the Reality, and the Future of Biotech. Boston, MA: Harvard Business School Press. pp. 1-20.
64. Pollack, A. (2004) Is biotechnology losing its nerve? The New York Times, February 29, p. 1.
65. Rice, M.P., Kelley, D., Peters, L., and O'Connor, G.C. (2001) Radical innovation: triggering initiation of opportunity recognition and evaluation. R&D Management, 31, 4, 409-420.
66. Rickne, A. and Jacobsson, S. (1999) New technology-based firms in Sweden - a study of their direct impact on industrial renewal. Economic Innovations New Technologies, 8, 197-223.
67. Rothaermel, F.T. and Deeds, D.L. (2004) Exploration and exploitation alliances in biotechnology: a system of new product development. Strategic Management Journal, 25, 3, 201-221.
68. Scott, J.T. (2003) Absorptive capacity and the efficiency of research partnerships. Technology Analysis & Strategic Management, 15, 2, 247-253.
69. Sheremata, W.A. (2000) Centrifugal and centripetal forces in radical new product development under time pressure. Academy of Management Review, 25, 2, 389-408.
70. Simon, H.A. (1973) Technology and environments. Management Science, 19, 1110-1121.
71. Smith, K.G., Collins, C.J., and Clark, K.D. (2005) Existing knowledge, knowledge creation capability and the rate of new product introduction in high-technology firms. Academy of Management Journal, 48, 2, 346-357.
72. Stock, G.N., Greis, N.P., and Fischer, W.A. (2001) Absorptive capacity and new product development. The Journal of High Technology Management Research, 12, 1, 77-91.
73. Tushman, M.L. (1977) Special boundary roles in the innovation process. Administrative Science Quarterly, 22, 587-605.
74. Vega-Jurado, J., Gutiérrez-Gracia, A., and Fernàndez-de-Lucio, I. (2008) Analyzing the determinants of firm's absorptive capacity: beyond R&D. R&D Management, 38, 4, 392-405.
75. Watts, A.D. (2008) How science matters: absorptive capacity, organizational forms, and performance in high technology firms. Unpublished dissertation. Temple University.
76. Watts, A.D. and Hamilton, R.D. (2011) Scientific foundation, organization structure, and performance of biotechnology and pharmaceutical firms. Journal of High Technology Management Research, 22, 2, 81-93.
77. Wolfe, D.A. (2005) The role of universities in regional development and cluster formation. In: Jones, G., McCarney, P., and Skolnick, M. (eds), Creating Knowledge, Strengthening Nations. Toronto: University of Toronto Press. pp. 167-194.
78. Zahra, S.A. and George, G. (2002) Absorptive capacity: a review, reconceptualization, and extension. Academy of Management Review, 27, 2, 185-203.
79. Zucker, L.G., Darby, M.R., and Brewer, M.B. (1998) Intellectual human capital and the birth of the U.S. biotechnology enterprises. The American Economic Review, 88, 1, 290-306.